Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment INMS

Neurology

Volumn 76, Issue 6, 2011, Pages 574-576

  Vennegoor, A ^a   Wattjes, M P ^a   Van Munster, E T L ^b   Kriekaart, R L ^b   Van Oosten, B W ^a   Barkhof, F ^a   Killestein, J ^a   Polman, C H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GADOLINIUM; GLATIRAMER; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NATALIZUMAB;

ADULT; ANAMNESIS; ARTICLE; ATAXIA; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DELIRIUM; DEPRESSION; DISEASE COURSE; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOADSORPTION; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SENSORY DYSFUNCTION; VIRUS LOAD; WALKING DIFFICULTY;

EID: 79951636324     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820b7644     Document Type: Article

References (4)

1. Clifford DB, DeLuca A, Simpson DM, et al. Progressive multifocal leukoencephalopathy with natalizumab treatment of multiple sclerosis. Neurology 2010;74(suppl 2): PL01.003.
2. Clifford DB, DeLuca A, Simpson DM, et al. Natalizumab-associated progressive multifocal leukoen-cephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010;9:438-446.
3. Linda H, von Heijne A, Major EO, et al. Progressive mul-tifocal leukoencephalopathy after natalizumab mono-therapy. N Engl J Med 2009;361:1081-1087.
4. Langer-Gould A, Atlas SW, Green AJ, et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005;353:375-381. (Pubitemid 41132342)